The University of Texas MD Anderson Cancer Center
Dr. Wefel is a tenured Associate Professor and Chief of the Section of Neuropsychology with joint appointments in the Department of Neuro-Oncology and the Department of Radiation Oncology at The University of Texas MD Anderson Cancer Center.
He obtained his PhD in Clinical Psychology (Neuropsychology) from the University of Houston, completed his residency at the University of Chicago, and subsequently his fellowship in the Department of Neuro-Oncology at MD Anderson.
Dr. Wefel’s extramurally funded research seeks to characterize the prevalence, pattern, course, risks, and biologic and neural substrates for the development of cognitive dysfunction associated with cancer and cancer therapies. Ultimately, this will lead to identification and testing of interventions to prevent and/or minimize cognitive dysfunction. He is the cognitive study chair on numerous cooperative group, industry sponsored and investigator initiated trials involving patients with central nervous system and non-CNS cancer, many of which integrate cognitive and neuroimaging outcomes as well as exploration of genetic moderators of cognitive and brain outcomes. He has published over 100 manuscripts and book chapters.
Dr. Wefel is an Executive Committee Member of the Brain Tumor Center at MD Anderson, Founder of the International Cognition and Cancer Task Force, Executive Board Member of the RTOG/NRG Oncology Brain Tumor Committee and Patient Centered Outcome Committee, Member of the National Brain Tumor Society (NBTS) Medical Advisory Board, Member of the American Brain Tumor Association Clinical Advisory Committee, Steering Committee Member of the NBTS Jumpstarting Brain Tumor Drug Development Coalition and FDA Clinical Trials Clinical Outcome Assessment Endpoints workshop, and has been appointed as the SNO Executive Editor of the journal Neuro-Oncology Practice.